Literature DB >> 1302026

The gene responsible for familial hypocalciuric hypercalcemia maps to chromosome 3q in four unrelated families.

Y H Chou1, E M Brown, T Levi, G Crowe, A B Atkinson, H J Arnqvist, G Toss, G E Fuleihan, J G Seidman, C E Seidman.   

Abstract

Familial hypocalciuric hypercalcemia (FHH) is an autosomal dominant syndrome of unknown aetiology characterized by lifelong elevation in serum calcium concentration and low urinary calcium excretion. These features suggest that the causal gene is important for maintenance of extracellular calcium homeostasis by the parathyroid gland and kidney. To identify the chromosomal location of FHH gene(s), we clinically evaluated 114 individuals in four unrelated affected families and performed linkage analyses. The disease gene mapped to the long arm of chromosome 3 in each family (combined maximum multipoint lod score = 20.67). We suggest that this is the predominant FHH locus and anticipate that identification of the FHH gene will improve our understanding of the molecular basis for physiologic and pathologic regulation of calcium.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1302026     DOI: 10.1038/ng0792-295

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  25 in total

Review 1.  Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.

Authors:  Stephen J Marx; David Goltzman
Journal:  J Bone Miner Res       Date:  2018-12-10       Impact factor: 6.741

2.  In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia.

Authors:  M Bai; S H Pearce; O Kifor; S Trivedi; U G Stauffer; R V Thakker; E M Brown; B Steinmann
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

Review 3.  International Union of Basic and Clinical Pharmacology. CVIII. Calcium-Sensing Receptor Nomenclature, Pharmacology, and Function.

Authors:  Katie Leach; Fadil M Hannan; Tracy M Josephs; Andrew N Keller; Thor C Møller; Donald T Ward; Enikö Kallay; Rebecca S Mason; Rajesh V Thakker; Daniela Riccardi; Arthur D Conigrave; Hans Bräuner-Osborne
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

Review 4.  Familial hypocalciuric hypercalcemia and related disorders.

Authors:  Janet Y Lee; Dolores M Shoback
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2018-05-26       Impact factor: 4.690

5.  Mutations in the human Ca(2+)-sensing-receptor gene that cause familial hypocalciuric hypercalcemia.

Authors:  Y H Chou; M R Pollak; M L Brandi; G Toss; H Arnqvist; A B Atkinson; S E Papapoulos; S Marx; E M Brown; J G Seidman
Journal:  Am J Hum Genet       Date:  1995-05       Impact factor: 11.025

6.  A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2.

Authors:  L Thierfelder; C MacRae; H Watkins; J Tomfohrde; M Williams; W McKenna; K Bohm; G Noeske; M Schlepper; A Bowcock
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

7.  A case report of familial benign hypocalciuric hypercalcemia: a mutation in the calcium-sensing receptor gene.

Authors:  Seong Ill Woo; Hyunju Song; Kyung Eun Song; Dae Jung Kim; Kwan Woo Lee; Se Joong Kim; Yoon-Sok Chung
Journal:  Yonsei Med J       Date:  2006-04-30       Impact factor: 2.759

8.  Insertion of an Alu sequence in the Ca(2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

Authors:  N Janicic; Z Pausova; D E Cole; G N Hendy
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

Review 9.  Familial benign hypercalcemia--from clinical description to molecular genetics.

Authors:  H Heath
Journal:  West J Med       Date:  1994-06

10.  Independent origin of identical beta cardiac myosin heavy-chain mutations in hypertrophic cardiomyopathy.

Authors:  H Watkins; L Thierfelder; R Anan; J Jarcho; A Matsumori; W McKenna; J G Seidman; C E Seidman
Journal:  Am J Hum Genet       Date:  1993-12       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.